Production of stromal cell-derived factor-1 (SDF-1)and expression of CXCR4 in human bone marrow endothelial cells. by Yun, Hwan-Jung & Jo, Deog-Yeon
INTRODUCTION
Bone marrow endothelial cells (BMECs) support the pro-
liferation and differentiation of hematopoietic progenitors via
production of various cytokines and also possibly via physical
contact (1). In addition, their anatomic location suggests that
BMECs play an important role in hematopoietic cell traffick-
ing (2, 3). Therefore, BMECs should somehow differ from
endothelial cells outside the bone marrow, and be specialized
for their expected role. Indeed, BMECs support the adhesion
and migration of hematopoietic progenitors better than human
umbilical vein endothelial cells (HUVECs) or lung-derived
endothelial cells (4-6). The sulfation patterns of heparan sul-
phate derived from human BMECs differ from those of
HUVECs (7). The expression of adhesion molecules of prima-
ry human BMECs and their regulation by cytokines do not
differ much from those of HUVECs (4).
Stromal cell-derived factor-1 (SDF-1), a CXC chemokine
constitutively expressed and produced by bone marrow stro-
mal cells, induces chemotaxis of both committed and prim-
itive hematopoietic progenitors via its receptor, CXCR4 (8-
11). A concentration gradient of SDF-1 across the endothelium
in the bone marrow seems to be the major mechanism for bone
marrow homing of hematopoietic stem cells and progenitor
cells (12, 13). It has been reported that murine BMECs express
SDF-1 mRNA and that its conditioned medium has chemo-
tactic activity, which is abrogated with anti-SDF-1 antibody,
suggesting the release of SDF-1 from BMECs (14). Another
group, however, failed to find chemotactic activity on hem-
atopoietic progenitors in murine BMEC-conditioned medi-
um, although the cells strongly expressed SDF-1 mRNA and
the presence of SDF-1 in human BMECs was demonstrated
using immunohistochemistry of bone marrow sections (15, 16).
Therefore, it is still not clear whether human BMECs actively
release SDF-1 and what role BMEC-derived SDF-1 may play
in hematopoietic cell trafficking. It is well known that endothe-
lial cells, including HUVECs, generally express CXCR4 and
respond to SDF-1, resulting in cell chemotaxis (17). Signalling
via CXCR4 seems to be crucial in both pre- and postnatal an-
giogenesis (18, 19). However, it is not known whether BMECs
also express CXCR4. This study investigated the production
and secretion of SDF-1 and the expression of CXCR4 in human
BMECs.
MATERIALS AND METHODS
Cells and Cell Lines
BMEC-1 cells were generated by introducing the SV-40
large T antigen into an early passage of primary BMECs (20).
Cells were cultured in Medium-199 (Gibco BRL Life Tech-
nologies, Grand Island, NY, U.S.A.) with 10 to 20% fetal
bovine serum (FBS; Gibco) and passaged weekly. The cells are
contact-inhibited and express adhesion molecules like prima-
ry BMECs (21). HUVECs were prepared as described previ-
ously (21) and cultured in Medium-199 (Gibco) supplement-
ed with 20% FBS, 2 mmol/L L-glutamine, 5 U/mL heparin,
100 IE/mL penicillin, 100  g/mL streptomycin, and 50  g/
mL endothelial cell growth supplements (ECGS; Biomedi-
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Production of Stromal Cell-Derived Factor-1 (SDF-1) and Expression
of CXCR4 in Human Bone Marrow Endothelial Cells
This study investigated the production of stromal cell-derived factor-1 (SDF-1) and
the expression of CXCR4 in human bone marrow endothelial cells (BMECs). Human
BMEC cell line BMEC-1 cells expressed SDF-1 mRNA, and conditioned medium
induced chemoattraction of CD34+ cells. Migration was not inhibited by pretreating
the input cells with pertussis toxin, indicating that the chemoattractive activity was
not dependent on SDF-1. Three-day culture of BMEC-1 and primary human BMEC
cells produced 1,710±204 and 1,050±153 pg/mL SDF-1 , respectively, which was
much less than primary human BM stromal cells (29,536±532 pg/ mL). By immuno-
histochemistry, CXCR4 was detected in the endothelial cells lining sinusoids, arte-
rioles, and venules in the bone marrow. However, cultured BMECs and BMEC-1
cells did not express CXCR4 on their surfaces. These results indicate that BMECs
produce and release small amounts of SDF-1 and express CXCR4 in vivo only.
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cal Technologies, Inc. Stoughton, MA, U.S.A.), hereafter re-
ferred to as EC medium. Early passages were used in the exper-
iments. Primary human BMECs were isolated using the me-
thod of Rafii et al. (4) with some modifications. Bone marrow
aspirates were obtained after informed consent from normal
donors undergoing bone marrow harvest. Bone marrow spi-
cules, obtained by filtration through a 40-micron filter, were
washed and digested with 0.1% collagenase (Sigma, St. Louis,
MO, U.S.A.) for 15 min at 37℃. After washing, both loose
cells and particles were plated onto gelatin-coated tissue cul-
ture flasks (Falcon, Franklin Lakes, NJ, U.S.A.) and grown in
EC medium. After reaching confluence, they were passaged
and endothelial cells were selected using the MACS system
(Miltenyi Biotec, Auburn, CA, U.S.A.). First, the cells were
incubated with phycoerythrin (PE)-conjugated anti-CD31
(PECAM-1) monoclonal antibody (MoAb) (BD PharMingen,
San Diego, CA, U.S.A.), and then reacted with anti-PE MoAb-
coated microbeads (Miltenyi Biotec). PE-positive cells were
selected using MACS columns according to the manufactur-
er’ s instructions. Only cultures containing at least 80% von
Willebrand factor (vWF)-expressing cells were used in the
experiments.
Murine bone marrow stromal cells MS-5 (22) were grown
in MEM- (Gibco) supplemented with 10% FBS and passaged
weekly. The cells support the proliferation of primitive human
hematopoietic cells in long-term culture (23) and secrete SDF-
1 (8). Primary human bone marrow stromal cells were obtained
as described previously (24). CD34-negative cells, obtained
after purification of CD34+cells from bone marrow mononu-
clear cells, were cultured in MEM- supplemented with 12.5%
FBS, 12.5% horse serum (Gibco), 10-6M hydrocortisone (Si-
gma), 5×10-5 M 2-mercaptoethanol (Sigma), streptomycin,
and penicillin, hereafter referred to as LTC medium. After
reaching confluence, adherent cells were harvested and main-
tained in LTC medium with weekly passage. After three pas-
sages, neither CD45+cells nor PECAM-1+cells were detect-
ed by flow cytometric analysis.
Growth factor-dependent human myeloid leukemic cells,
MO7e, were cultured in IMDM (Gibco BRL Life Technolo-
gies) supplemented with 10% FBS and 10 ng/mL granulo-
cyte, macrophage colony-stimulating factor (GM-CSF; Lucky
Biotec, Daejon, Korea). The cells strongly expressed CXCR4
and responded to SDF-1, resulting in chemotaxis (9).
Purification of CD34+ Cells
CD34+ cells were purified from bone marrow obtained
from normal donors undergoing bone marrow harvest with
informed consent. After Ficoll isolation, the mononuclear cells
were incubated with anti-CD34 MoAb-coated microbeads
(Miltenyi Biotec). Bead-positive cells were isolated using the
MACS system according to the manufacturer’ s instructions.
Only cells with purity of 95% or more in flow cytometric anal-
ysis were used in the experiments.
Flow Cytometry
A total of 5×104 to 1×105 cells was incubated at 4℃ for
30 min with fluorescein isothiocyanate (FITC)- or PE-con-
jugated MoAb, and analysed using a Coulter Elite flow cytome-
ter (Coulter Electronics Ltd., Hialeah, FL, U.S.A.). Isotype-iden-
tical antibodies served as controls. The monoclonal antibod-
ies used in the study were as follows: FITC-conjugated anti-
CD34 MoAb (HPAC-2; Becton-Dickinson, San Jose, CA,
U.S.A.), PE-conjugated anti-CXCR4 MoAb (12G5; BD
PharMingen), PE-conjugated anti-CD45 MoAb (BD PharMin-
gen), and PE-conjugated anti-CD106 MoAb (VCAM-1; BD
PharMingen).
Reverse Transcriptase-polymerase Chain Reaction
(RT-PCR)
Using TrizolTM‚ (Gibco-BRL, Burlington, Ontario, Canada),
RNA was prepared from HUVECs, BMEC-1 cells, MO7e
cells, and primary bone marrow stromal cells according to the
manufacturer’ s instructions. After purification, 1  g of RNA
was reverse-transcribed using SuperScript reverse transcrip-
tase (Gibco-BRL) and universal primer oligo dT15 (Promega,
Madison, WI, U.S.A.). One  L of cDNA was added to 24  L
of PCR buffer (Gibco-BRL) supplemented with 2 mmol/L
MgCl2, 0.2  mol/L specific primers, and 1 U/reaction tube
of Koma Taq polymerase (Koma International, Seoul, Korea).
PCR was performed at 94℃for 1 min, at 55-65℃for 45 sec,
and at 72℃for 1 min for 30 cycles on a GeneAmp PCR sys-
tem (Perkin Elmer, Norwalk, CT, U.S.A.). The following pr-
imers were used: CXCR4 sense-AAT CTT CCT GCC CAC
CAT CTA CTC C; antisense-GCG GTC ACA GAT ATA
TCT GTC ATC TGC C; SDF-1 sense-TGA TCG TCT GAC
TGG TCT TA; anti-sense-CTT AGG GGA TTT GGA AGT
TT; GAPDH sense-TGA AGG TCG GAG TCA ACG GAT
TTG GTC; antisense-CAT GTG GGC CAT GAG GTC
CAC CAC.
Preparation of Conditioned Medium (CM)
BMECs, HUVECs, MS-5, and primary human bone mar-
row stromal cells were grown in the proper medium for each
in T25 culture flasks. After reaching confluence, the cultures
were thoroughly washed, and 3 mL of serum-free medium X-
VIVO (Biowhittacker, Walkersville, MA, U.S.A.) was added
to each flask. After a 72-hr incubation at 37℃, the supernatants
were harvested, filtered using 2  m membranes, and stored at
4℃ until used. As indicated, cytokines were added at the
beginning of the cultures for the preparation of conditioned
medium. The following cytokines were used: interleukin-1
(IL- ; 10 ng/mL), interleukin-3 (IL-3; 50 ng/mL), interleukin-
6 (IL-6; 20 ng/mL), stem cell factor (SCF; 100 ng/mL), inter-
feron-gamma (IFN- ; 100 U/mL), tumour necrosis factor-alpha
(TNF- ; 10 ng/mL), transforming growth factor-beta 1 (TGF-Production of SDF-1 in Bone Marrow Endothelial Cells 681
1; 10 ng/mL) (all of the above were purchased from R&D Sys-
tems), granulocyte colony-stimulating factor (G-CSF; 100 ng/
mL) (a gift from Kirin, Tokyo, Japan), and GM-CSF (100 ng/
mL). As indicated, heparinase (Sigma) was added at concen-
trations of 10, 20, 50, or 100 U/mL.
Transmigration Assay
The TranswellTM system (Corning-Costar, Cambridge, MA,
U.S.A.) was used, as previously described (11). CD34+ cells
or MO7e cells (2-2.5×105 cells per well) were loaded into
the upper chamber of a 24-well Transwell with a 3  m
microporous membrane, and SDF-1, cytokines, or conditioned
media were added to the lower chamber. The cells were allowed
to migrate into the lower chamber for the indicated period.
For blocking experiments, CD34+ cells were pre-incubated
with 200  g/mL of PTX (Sigma) at 37℃for 2 hr.
Enzyme-linked Immunosorbent Assay (ELISA)
The concentrations of SDF-1 and SCF in conditioned media
were measured using commercial ELISA kits (R&D Systems)
according to the manufacturer’ s instructions. Optical density
was measured using a spectrophotometer (Molecular Device
Co., Sunnyvale, CA, U.S.A.). The standard curves and levels
of SDF-1 or SCF were obtained using the program SoftmaxTM
(Molecular Device Co.).
Immunohistochemistry
Immunohistochemical staining was performed on forma-
lin-fixed, paraffin-embedded human bone marrow sections.
Anti-human CXCR4 monoclonal antibody (R&D Systems)
was diluted (1:200), and immunostaining was performed using
an LSAB kit (DAKO, Carpinteria, CA, U.S.A.). After pre-incu-
bation with goat serum for 15 min, bone marrow sections were
incubated overnight with anti-CXCR4 antibody at 4℃ in
a humid chamber. After washing, the slides were incubated
for 30 min with a linking solution containing biotinylated
goat anti-mouse IgG, and sequentially incubated with strep-
tavidin peroxidase for 30 min and with 3,3-diaminobenzidine
(DAB) for 5 min. Slides were counterstained with Mayer’ s
hematoxylin. Isotype-matched antibody was used as a nega-
tive control.
Statistical Analysis
The results are expressed as the means±SD of three or more
independent experiments. Data were analysed using Student’ s
t-test for paired or unpaired samples. A p value of less than
0.05 was considered significant.
RESULTS
Expression of CXCR4 and SDF-1 in BMECs and
HUVECs
In flow cytometric analyses, BMEC-1 cells did not express
CXCR4. In contrast, HUVECs strongly expressed CXCR4,
and this was highly up-regulated by IL-1 as shown in pre-
vious studies (Fig. 1) (17). RT-PCR also revealed that BMEC-
1 cells did not express CXCR4 mRNA, whereas HUVECs
strongly expressed it. Incubation of BMEC-1 cells with var-
Fig. 1. Flow cytometric analysis of CXCR4 and adhesion molecule expression on BMEC-1 cells and human umbilical vein endothelial
cells (HUVECs). BMEC-1 cells do not express CXCR4, whereas HUVECs strongly express it, and this is upregulated by treatment with IL-
1 (10 ng/mL) for 24 hr. Arrow heads indicate basal expression of CXCR4 and adhesion molecules.
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ious cytokines for up to 40 hr did not induce the expression
of mRNA or cell surface protein for CXCR4. Interestingly,
CXCR4 was consistently detected in the endothelial cells lin-
ing the sinusoids, venules, and arterioles of the bone marrow
using immunohistochemistry (Fig. 2). SDF-1 mRNA was
detected in BMECs-1 cells by RT-PCR, but not in HUVECs.
Its expression, however, was much less than that of primary
human bone marrow stromal cells (Fig. 3).
Chemoattractive Activities of BMEC CM and HUVEC
CM on Hematopoietic Progenitor Cells
While 0.3±0.2% of bone marrow CD34+ cells migrated
in controls in 4 hr, BMEC-1 CM induced the migration of
2.5±1.5% of the cells; the migration , however, did not dif-
fer from the value for HUVEC CM (1.7±0.5%, p=0.1), but
was far less than for MS-5 CM (19.6±11.0%, p<0.01). Pre-
treatment of CD34+ cells with pertussis toxin did not affect
BMCE-1 CM- or HUVEC CM-mediated migration, but it
markedly inhibited the migration of cells induced by MS-5
CM (Fig. 4). To clarify whether cytokines modulate the
chemoattractive activities of BMEC-1 cells, the cells were
incubated with some cytokines and the chemoattractive activ-
ity of the CM was measured. IL-1 -treated CM had increased
and TNF- -treated CM had markedly decreased chemoat-
C D
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Fig. 2. Immunohistochemical staining for CXCR4 in normal (A, B; ×200) and acellular (C, D; ×100) bone marrow. CXCR4 is detected in
endothelial cells lining the sinusoids (A) and small vessels (B-D) (small arrows). A megakaryocyte (thick arrow) strongly stained for CXCR4
is shown (A).
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Fig. 3. Expression of SDF-1 and CXCR4 mRNA detected using RT-
PCR in MO7e cells, human umbilical endothelial cells (HUVECs),
BMEC-1 cells, and primary bone marrow stromal cells. The exper-
iment was performed twice, and a representative experiment is
shown.traction of MO7e cells, respectively (Fig. 5).
Measuring SDF-1 and SCF in BMEC CM and HUVEC
CM
The concentrations of SDF-1 in three-day-old CM of en-
dothelial cells and bone marrow stromal cells were measured
by ELISA. SDF-1 was not detected in HUVEC CM, even
after various cytokine treatments. BMEC-1 CM and primary
human BMEC CM contained 1,710.7±204 and 1,050±
153 pg/mL SDF-1 , which were much lower than with pri-
mary bone marrow stromal cell CM (29,536±532 pg/mL,
p<0.001) or MS-5 CM (101,791±9,045 pg/mL, p<0.001)
(Table 1). It was markedly increased by treating BMEC-1 cells
with IL-1 and SCF, and abrogated by treatment with TNF- .
BMEC-1 CM and HUVEC CM contained 324±24 and 269
±14 pg/mL SCF, respectively; both of which were increased
by treating the cells with IL-1 or TNF- (Table 2). Proteo-
glycans on endothelial cells present adhesion-inducing cyto-
kines to leukocytes (25), and SDF-1 binds to glycosamino-
glycan on the cell surface (26). To clarify whether SDF-1 is
present on BMEC-1 cells, heparinase, which digests heparan
sulphate, was added to BMEC-1 cell culture, and the SDF-1
concentration in the culture supernatant was measured. The
addition of heparinase at the concentration of up to 100 U/mL
increased the concentration of SDF-1 in the culture super-
natant in a dose-dependent manner by up to 32.5±5% (data
not shown), indicating that SDF-1 was present on the cell
surface and released from glycosaminoglycan by enzymatic
cleavage.
DISCUSSION
SDF-1 and CXCR4 interaction is involved in both normal
cardiovascular development (18) and postnatal angiogenesis
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Fig. 4. Four-hour transmembrane migration of bone marrow CD34+
cells induced by BMEC-1 CM, human umbilical endothelial cell
(HUVEC) CM, and MS-5 CM. The data are from three independent
experiments. Twenty-four-well Transwells
TM‚ with 3- m pores were
used in the migration experiments. Input cells were pretreated with
pertussis toxin as indicated. *, p<0.05.
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Fig. 5. Four-hour transmembrane migration of MO7e cells induced
by cytokine-treated BMEC-1 conditioned medium. Twenty-four-well
Transwells
TM‚ with 3- m pores were used in the migration experiments.
The data are presented as the mean±SD of the percentages of trans-
migration from three independent experiments. *, p<0.05 compared
to control.
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Data are representatives of three independent experiments (mean±SD).
BMEC, bone marrow endothelial cells; BMSC, bone marrow stromal
cells; BDL, below detectable levels; NT, not tested.
Conditioned media SDF-1 (pg/mL) SCF (pg/mL)
BMEC-1 1,710±204 324±24
Primary BMEC 1,050±153 478±57
HUVEC BDL 269±68
Primary BMSC 29,536±532 1,685±92
MS-5 101,791±9,045 NT
Table 1. SDF-1 and SCF levels in conditioned medium mea-
sured using ELISA
Cytokines added
SDF-1 (pg/mL) SCF (pg/mL)
BMEC-1 HUVEC BMEC-1 HUVEC
No 1,710±204 BDL 324±24 269±14
IL-1 (10 ng/mL)  6,151±41* BDL 747±27* 605±68*
IL-3 (50 ng/mL) 1,537±122 BDL 307±17 NT
IL-6 (20 ng/mL) 1,984±204 BDL NT NT
G-CSF (100 ng/mL) 2,157±205 BDL 360±38 341±14
GM-CSF (100 ng/mL) 1,058±205 BDL NT NT
SCF (100 ng/mL) 4,068±368* BDL NT NT
IFN- (100 U/mL) 1,276±82 BDL 324±35 302±21
TNF- (10 ng/mL) 278±81* BDL 757±25* 583±43*
TGF- (10 ng/mL) 1,492±245 BDL 305±24 NT
Table 2. SDF-1 and SCF levels in cytokine-treated endothelial
cell conditioned medium measured using ELISA
Data are representatives of three independent experiments (mean±SD)
*p<0.05 compared to no-cytokine-treatment groups. BDL, below
detectable level; NT, not tested.(19). In this study, we showed that endothelial cells lining
the bone marrow vasculature also express CXCR4, although
it is not detected in cultured BMECs or BMEC-1 cells. It is
not clear why cultured BMECs lose their ability to express
CXCR4, whereas HUVECs preserve it well. Recently, time-
dependent changes in CXCR4 expression and localization
during extracellular matrix-dependent endothelial tube for-
mation of HUVECs were observed (27). BMECs may lose
their ability to express CXCR4 when they are not in the vas-
culature.
Skin endothelial cells produce and secrete SDF-1 (28). Peled
et al. (15) found no evidence that HUVECs produced SDF-
1, while Salvucci et al. (27) observed SDF-1 production by
HUVECs, especially in the presence of vascular endothelial
growth factor (VEGF) or basic fibroblast growth factor (bFGF).
We could not detect SDF-1 mRNA in HUVECs. Furthermore,
SDF-1 was not detected in culture supernatant of HUVECs
incubated in serum-free conditions using ELISA. Taken to-
gether, SDF-1 production by HUVECs is minimal and is de-
pendent on the presence of certain cytokines, such as VEGF
or bFGF.
Imai et al. (14) reported that murine BMECs expressed
SDF-1 mRNA, and that the conditioned medium had chemo-
tactic activity that was blocked by anti-SDF-1 antibody. How-
ever, they did not compare the chemoattractiveness of BMEC
CM and bone marrow stromal cell CM. Peled et al. (15) proved
the presence of SDF-1 in BMECs in human bone marrow sec-
tions using immunohistochemistry. However, they could not
find chemoattractive activity in murine BMEC CM, although
the cells expressed SDF-1 mRNA. Therefore, it remains unclear
whether human BMECs secrete SDF-1, and whether the amo-
unt of SDF-1 released from BMECs is comparable to that from
bone marrow stromal cells. In this study, we showed that
BMECs secrete soluble chemoattractive factors for hematopoi-
etic progenitors. BMEC-1 CM in the lower chamber of the
TranswellTM induced migration of CD34+ cells. The failure
of pretreating the cells with pertussis toxin to block transmi-
gration indicates that SDF-1 is not a predominant chemoat-
tractive factor released from BMECs. In agreement with this,
much less SDF-1 was secreted from BMECs than from prima-
ry human bone marrow stromal cells or a murine bone mar-
row stromal cell line, MS-5. The expression of SDF-1 mRNA
by BMEC-1 was also much lower than by bone marrow stro-
mal cells. These results indicate that BMECs are not the major
source of the high concentration of SDF-1 in the bone mar-
row microenvironment, and strengthens the possibility that
SDF-1 produced by BMECs has additional roles. It has been
shown that SDF-1 and SCF cooperate in inducing chemotaxis
and chemokinesis of hematopoietic progenitor cells (9), pos-
sibly by sharing common signalling pathways (29). The
chemoattractive activity produced by BMECs might be due
to the additive or synergistic actions of some chemoattractive
factors. We showed that the production and secretion of SDF-
1 from BMECs is regulated by cytokines, including some
hematopoietic growth factors. Further studies on the impli-
cations of modulation of SDF-1 production by BMECs are
needed. IL-1 -treated BMEC-1 CM had enhanced chemoat-
tractive activity and TNF- -treated BMEC-1 CM had atten-
uated chemoattractive activity on MO7e cells. It remains un-
clear whether the modulation of SDF-1 production or secre-
tion by the cytokines could be responsible for the changes in
chemoattraction.
It has been suggested that transendothelial migration of
hematopoietic progenitors is characteristic of BMECs, based
on the finding that murine BMECs supported the transmigra-
tion of hematopoietic progenitors, while lung endothelial cells
did not (6). This is untrue, since HUVECs support adhesion
and both spontaneous and SDF-1-induced transendothelial
migration of hematopoietic progenitors to some extent (16).
It has been suggested that SDF-1, especially the surface-bound
form, activates the adhesion molecules of hematopoietic pro-
genitors, thereby enhancing adhesion of the cells to endothe-
lial cells (15, 16), although a contradictory report found that
SDF-1 suppresses the cytokine-induced adhesion of hemato-
poietic progenitors to immobilized fibronectin (30). We showed
that incubating BMEC-1 cells with heparinase increased the
SDF-1 concentration in the culture supernatant, indicating
the presence of SDF-1 on the cell surface. Indeed, SDF-1 anti-
body decreased the adhesion of hematopoietic progenitors to
BMECs (14), and pretreatment of HUVECs with SDF-1 en-
hanced the adhesion of hematopoietic progenitor cells (16).
Taken together, it is possible that BMEC-derived SDF-1 en-
hances the transendothelial migration of hematopoietic pro-
genitor cells.
In conclusion, human BMECs express CXCR4 in vivo and
produce and release small amounts of SDF-1, which might
favors bone marrow endothelium, with better transmigra-
tion of haematopoietic cells.
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